STOCK TITAN
  1. Home
  2. News
  3. TLRY

Tilray to Report 2020 Full Fiscal Year and Fourth Quarter Financial Results on February 17, 2021

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings

Tilray Inc. (“Tilray” or the “Company”) (Nasdaq: TLRY), a global pioneer in cannabis production, research, cultivation and distribution, announced today it will report results for 2020 full fiscal year and fourth quarter ended December 31, 2020 on Wednesday, February 17, 2021 after market close.

The Company will host a conference call to discuss these results at 5:00 p.m. ET. Investors interested in participating in the live call can dial 877-407-0792 from the U.S. and 201-689-8263 internationally.

There will also be a simultaneous, live webcast available on the Investors section of the Company’s website at www.tilray.com. The webcast will be archived after the conference call concludes.

About Tilray®
Tilray is a global pioneer in the research, cultivation, production, and distribution of cannabis and cannabinoids, currently serving tens of thousands of patients and consumers in 17 countries spanning five continents.

Stock TLRY logo
Tilray Brands, Inc.

NASDAQ:TLRY

TLRY Rankings

#2107 Ranked by Market Cap
#4865 Ranked by Stock Gains
N/A Ranked by Dividends

TLRY Latest News

May 17, 2024
Tilray Brands Announces At-The-Market Program to Fund Strategic and Accretive Acquisitions and Accelerate Expansion Plan Upon U.S. Cannabis Rescheduling When Effective
May 16, 2024
SweetWater Brewing Launches New Sunset Sippin’ Cocktail Inspired Hard Seltzers
May 14, 2024
Breckenridge Brewery Announces On Tap with KBCO Concert Series Featuring Cannons, The Moss and Dehd
May 3, 2024
10 Barrel Brewing Introduces Pub Cerveza: a New Twist on ‘Cheap Fun.’ Series
May 2, 2024
Tilray Brands Launches XMG Zero, a New ‘Better for You’ Cannabis Beverage

TLRY Stock Data

1.59B
770.48M
1.33%
10.98%
15.42%
Medicinal and Botanical Manufacturing
Manufacturing
Link
United States of America
NEW YORK

About TLRY

tilray is a global leader in medical cannabis research and production dedicated to providing safe, consistent and reliable therapy to patients. we are the only gmp certified medical cannabis producer currently supplying products to thousands of patients, physicians, pharmacies, hospitals, governments and researchers in australia, canada, the european union and the americas.